Skip to main content
. Author manuscript; available in PMC: 2013 Mar 20.
Published in final edited form as: Br J Haematol. 2008 Oct 16;143(5):641–653. doi: 10.1111/j.1365-2141.2008.07340.x

Table I.

Patient characteristics and clinical outcome.

Subject Age (years) Sex Status at enrolment Number of prior autotransplants Metaphase cytogenetics Best response on protocol Outcome on protocol Salvage therapy Current status Cause of death
1 55 F Refractory relapse 2 Abnormal n-CR Relapse day 77 Yes Dead day 201 PD
2 52 F Relapse 1 Abnormal CR Relapse day 133 Yes Dead day 615 Pneumonia post further PBSCT for PD
3 62 M Refractory relapse 1 Abnormal n-CR Relapse day 31 Yes CR & alive day 1111 N/A
4 56 M Refractory relapse 2 Normal PD PD Yes Dead day 825 PD
5 67 M Relapse 2 Abnormal CR Relapse day 532 Yes n-CR & alive day 850 N/A
6 48 M Relapse 2 Normal PD PD Yes Dead day 206 PD
7 49 M Relapse 2 Abnormal PR Relapse day 75 Yes Dead day 285 PD
8 50 M Refractory relapse 1 Abnormal MR Relapse day 58 Yes Dead day 202 PD
9 60 M Relapse 1 Normal SD SD No SD & alive day 533 N/A
10 44 M Relapse 2 Abnormal n-CR Relapse day 259 Yes n-CR & alive day 541 N/A

F, female; M, male; CR, complete remission; n-CR, near complete remission; PR, partial response; MR, minimal response; SD, stable disease; PD, progressive disease; N/A, not applicable; PBSCT, peripheral blood stem cell transplantation.